NASDAQ: BODIBeachbody Company Inc Stock
$11.77+0.89 (+8.18%)
Updated Dec 18, 2025
BODI Price
$11.77
Fair Value Price
N/A
Market Cap
$83.43M
52 Week Low
$3.38
52 Week High
$12.33
P/E
-1.89x
P/B
3.38x
P/S
0.15x
PEG
N/A
Dividend Yield
N/A
Revenue
$282.57M
Earnings
-$42.64M
Gross Margin
72%
Operating Margin
-13.08%
Profit Margin
-15.1%
Debt to Equity
4.93
Operating Cash Flow
$10M
Beta
1.24
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
BODI Overview
Beachbody Company Inc is a fitness and media company Its brands are Beachbody On Demand, Team Beachbody, MYXfitness, and Openfit. The company also sells dietary supplements (Shakeology and Beachbar) through direct response infomercials and multi-level marketing via Team Beachbody "coaches" who serve as sales consultants. The company's digital streaming platform includes a library of 4,570 workouts. Beachbody wasfounded in 1998 and is headquartered in Santa Monica, CA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine BODI's potential to beat the market
- BODI doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Internet Content & Information
Industry Rating
C
BODI
RankedUnranked of 52
RankedUnranked of 52
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $15.02 | A | |
| $4.03 | A | |
| $12.94 | A |
Be the first to know about important BODI news, forecast changes, insider trades & much more!
BODI News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how BODI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BODI is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BODI is good value based on its book value relative to its share price (3.38x), compared to the US Internet Content & Information industry average (8.14x)
P/B vs Industry Valuation
BODI is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more BODI due diligence checks available for Premium users.
Valuation
BODI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.89x
Industry
31.13x
Market
44.14x
BODI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.38x
Industry
8.14x
BODI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
BODI's financial health
Profit margin
Revenue
$59.9M
Net Income
$3.6M
Profit Margin
6%
BODI's Earnings (EBIT) of -$36.95M... subscribe to Premium to read more.
Interest Coverage Financials
BODI's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$146.4M
Liabilities
$121.7M
Debt to equity
4.93
BODI's short-term liabilities ($93.08M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BODI's short-term assets ($60.38M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BODI's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
BODI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$10.2M
Investing
-$1.2M
Financing
-$274.0k
BODI's operating cash flow ($10.04M)... subscribe to Premium to read more.
Debt Coverage Financials
BODI vs Internet Content & Information Stocks
Beachbody Company Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.